gebhart/patrepeval huggingface dataset:
Selective Neuronal Vulnerability in HIV Encephalitis (1992)

Recent studies of human immunodeficiency virus type 1 (HIV-1) encephalitis have shown that in addition to well established white matter damage, the neocortex shows thinning, loss of large neurons and dendritic damage. In order to identify neuronal populations affected in HIV encephalitis and to determine how neuronal damage relates to the severity of HIV infection within the nervous system, we quantified parvalbumin (PV+) and neurofilament (NF+) immunoreactive neurons in the frontal cortex and hippocampus. We found that in the neocortex, the density of NF+ and PV+ neurons was independent of severity of HIV encephalitis, and therefore changes in these neuronal subsets did not account for previously reported neuronal loss. However, neuritic processes of PV+ neurons were fragmented, atrophic and in some cases distended. In contrast to the frontal cortex, there was a trend toward decreased density of PV+ neurons in the hippocampus which only reached significance in the CA3 layer where there was a 50-90% decrease in PV+ neurons. This decrease was closely correlated with the severity of HIV encephalitis. Double-label immunocytochemical analysis confirmed neuritic damage to interneurons. These results suggest that HIV encephalitis differentially involves specific subpopulations of neurons. Since direct HIV infection of neuronal cells was not detected, damage to PV+ cells and fibers may be indirectly mediated by cytokines released by HIV-infected microglia.
Chemical Composition, Antioxidant Properties, and Thermal Stability of a Phytochemical Enriched Oil from Açai (Euterpe oleraceaMart.) (2008)

Phenolic compounds present in crude oil extracts from acai fruit ( Euterpe oleracea) were identified for the first time. The stability of acai oil that contained three concentrations of phenolics was evaluated under short- and long-term storage for lipid oxidation and phenolic retention impacting antioxidant capacity. Similar to acai fruit itself, acai oil isolates contained phenolic acids such as vanillic acid (1,616 +/- 94 mg/kg), syringic acid (1,073 +/- 62 mg/kg), p-hydroxybenzoic acid (892 +/- 52 mg/kg), protocatechuic acid (630 +/- 36 mg/kg), and ferulic acid (101 +/- 5.9 mg/kg) at highly enriched concentrations in relation to acai pulp as well as (+)-catechin (66.7 +/- 4.8 mg/kg) and numerous procyanidin oligomers (3,102 +/- 130 mg/kg). Phenolic acids experienced up to 16% loss after 10 weeks of storage at 20 or 30 degrees C and up to 33% loss at 40 degrees C. Procyanidin oligomers degraded more extensively (23% at 20 degrees C, 39% at 30 degrees C, and 74% at 40 degrees C), in both high- and low-phenolic acai oils. The hydrophilic antioxidant capacity of acai oil isolates with the highest phenolic concentration was 21.5 +/- 1.7 micromol Trolox equivalents/g, and the total soluble phenolic content was 1252 +/- 11 mg gallic acid equivalents/kg, and each decreased by up to 30 and 40%, respectively, during long-term storage. The short-term heating stability at 150 and 170 degrees C for up to 20 min exhibited only minor losses (<10%) in phenolics and antioxidant capacity. Because of its high phenolic content, the phytochemical-enriched acai oil from acai fruit offers a promising alternative to traditional tropical oils for food, supplements, and cosmetic applications.
James F. Luhr (1953–2007) (2008)

Volcanologists worldwide were shocked to learn of Jim Luhr's sudden death at age 53 on 1 January 2007, at the zenith of his career. Jim was director of the Global Volcanism Program at the Smithsonian Institution in Washington, D.C. He lived in University Park, Md., with his wife, Karen, and two daughters.
The WiNAM project: Neural data analysis with applications to epilespy (2010)

This work presents a novel algorithmic method based on an ngram approach and applies it ECoG and deep brain neural data for analysis of epileptic seizures. This is part of a project (WiNAM) to design an analysis framework suitable for analysing brain dynamical changes. By first exploring the ngram model and its traditional use we describe how to apply it to biological data for pattern recognition. We then use this methodology and apply it to neurological data to show good sensitivity to seizure onset. Through these tests we explore the parameters used when computing the ngram to evaluate what is needed to maintain this sensitivity. Additionally, we present the analysis framework (an online system) that is being developed to carry out the ngram analysis and database the data and results.
Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt–Jakob Disease (2003)

Using sensitive techniques, we identified extraneural deposition of PrPSc in spleen and muscle samples from approximately one third of patients who died with sporadic Creutzfeldt-Jakob disease. Extraneural PrPSc appears to correlate with a long duration of disease.
Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts. (1995)

We have examined whether the secretion of erythropoietin (Epo) from genetically modified cells could represent an alternative to repeated injections of the recombinant hormone for treating chronic anemias responsive to Epo. Primary mouse skin fibroblasts were transduced with a retroviral vector in which the murine Epo cDNA is expressed under the control of the murine phosphoglycerate kinase promoter. "Neo-organs" containing the genetically modified fibroblasts embedded into collagen lattices were implanted into the peritoneal cavity of mice. Increased hematocrit (> 80%) and elevated serum Epo concentration (ranging from 60 to 408 milliunits/ml) were observed in recipient animals over a 10-month observation period. Hematocrit values measured in recipient mice varied according to the number of implanted Epo-secreting fibroblasts (ranging from 2.5 to 20 x 10(6)). The implantation of neo-organs containing Epo-secreting fibroblasts appeared, therefore, as a convenient method to achieve permanent in vivo delivery of the hormone. We estimated that the biological efficacy of the approach may be relevant for the treatment of human hemoglobinopathies.
Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases (2002)

Advances in genomics and proteomics have revolutionised the drug discovery process and target validation. Identification of novel therapeutic targets for chronic skeletal diseases is an extremely challenging process based on the difficulty of obtaining high-quality human diseased versus normal tissue samples. The quality of tissue and genomic information obtained from the sample is critical to identifying disease-related genes. Using a genomics-based approach, novel genes or genes with similar homology to existing genes can be identified from cDNA libraries generated from normal versus diseased tissue. High-quality cDNA libraries are prepared from uncontaminated homogeneous cell populations harvested from tissue sections of interest. Localised gene expression analysis and confirmation are obtained through in situ hybridisation or immunohistochemical studies. Cells overexpressing the recombinant protein are subsequently designed for primary cell-based high-throughput assays that are capable of screening large compound banks for potential hits. Afterwards, secondary functional assays are used to test promising compounds. The same overexpressing cells are used in the secondary assay to test protein activity and functionality as well as screen for small-molecule agonists or antagonists. Once a hit is generated, a structure-activity relationship of the compound is optimised for better oral bioavailability and pharmacokinetics allowing the compound to progress into development. Parallel efforts from proteomics, as well as genetics/transgenics, bioinformatics and combinatorial chemistry, and improvements in high-throughput automation technologies, allow the drug discovery process to meet the demands of the medicinal market. This review discusses and illustrates how different approaches are incorporated into the discovery and validation of novel targets and, consequently, the development of potentially therapeutic agents in the areas of osteoporosis and osteoarthritis. While current treatments exist in the form of hormone replacement therapy, antiresorptive and anabolic agents for osteoporosis, there are no disease-modifying therapies for the treatment of the most common human joint disease, osteoarthritis. A massive market potential for improved options with better safety and efficacy still remains. Therefore, the application of genomics and proteomics for both diseases should provide much needed novel therapeutic approaches to treating these major world health problems.
Specific Alterations in Transcript Prevalence During the Yeast Life Span (1989)

The budding yeast Saccharomyces cerevisiae has a finite life span, limited by the number of generations the cell can undergo. Yeast cells display a variety of changes as they age. In order to determine whether age-associated changes occur in the prevalence of specific mRNAs, a differential hybridization screen has been used to identify yeast genes that are preferentially expressed in either young or in old cells. In this screen, a yeast genomic DNA library was probed with cDNA prepared to the poly(A)+ mRNA of young and old cells. Six clones representing distinct genes that showed differential patterns of expression throughout the life span were isolated, as determined by genomic blot and RNA dot blot analyses. On the basis of their expression patterns five of the genes were classified as young- and one as old-specific. These genes were all derived from the nuclear genome. Analysis of the expression during the cell cycle of two of these genes, one young cell-specific and the other old-cell-specific, revealed that it was not growth state-dependent. These results suggest that aging in yeast is accompanied by defined alterations in the levels of certain gene transcripts.
A map of the human genome in linkage disequilibrium units (2005)

Two genetic maps with additive distances contribute information about recombination patterns, recombinogenic sequences, and discovery of genes affecting a particular phenotype. Recombination is measured in morgans (w) over a single generation in a linkage map but may cover thousands of generations in a linkage disequilibrium (LD) map measured in LD units (LDU). We used a subset of single nucleotide polymorphisms from the HapMap Project to create a genome-wide map in LDU. Recombination accounts for 96.8% of the LDU variance in chromosome arms and 92.4% in their deciles. However, deeper analysis shows that LDU/w, an estimate of the effective bottleneck time (t), is significantly variable among chromosome arms because (i) the linkage map is approximated from the Haldane function, then adjusted toward the Kosambi function that is more accurate but still exaggerates w for all chromosomes, especially shorter ones; (ii) the non-pseudoautosomal region of the X chromosome is subject to hemizygous selection; and (iii) at resolution less than approximately 40,000 markers per w, there are indeterminacies (holes) in the LD map reflecting intervals of very high recombination. Selection and stochastic variation in small regions must have effects, which remain to be investigated by comparisons among populations. These considerations suggest an optimal strategy to eliminate holes quickly, greatly enhance the resolution of sex-specific linkage maps, and maximize the gain in association mapping by using LD maps.
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study (2015)

PPV was safe and moderately effective based on serological response. Seropositivity to pneumococcal antigens significantly reduced the risk of infections. Sustained high-dose corticosteroids were associated with poor vaccine response and more infections.
The Emergence of Simian/Human Immunodeficiency Viruses (1992)

Molecular evolutionary analyses strongly support the hypothesis that human immunodeficiency viruses have recently arisen from a diverse pool of nonhuman primate immunodeficiency viruses. Our understanding of the molecular phylogenetic relationships between primate and nonprimate lentiviruses is less certain, partly because key intermediate forms are still to be discovered. DNA and protein sequence comparisons reveal uncanny dissimilarities, as well as similarities, among the genetic sequences of these complex retroviruses, thereby giving rise to the notion that primate lentiviruses are participants in "fast-forward" evolution.
Design and methods for a randomized clinical trial treating comorbid obesity and major depressive disorder (2008)

NCT00572520.
SLIM: Spectral localization by imaging (1988)

Nonspectroscopic magnetic resonance (MR) imaging often shows that a slice is composed of several compartments, each of which can be assumed to have a spatially homogeneous magnetic resonance spectrum, e.g., a limb composed of fat, muscle, bone marrow, and tumor. We show how to use structural information from such a nonspectroscopic image in order to increase the efficiency of subsequent localized spectroscopic measurements. Specifically, knowledge of the boundaries of N compartments makes it possible to reconstruct compartmental spectra from spectroscopic signals from an entire cross section with N or more different degrees of phase encoding. Experimental studies of a two-compartment phantom show that this method (SLIM) can be used to derive regional hydrogen spectra of a single slice from signals with as few as 2 phase-encoding steps, although Fourier transform chemical-shift imaging requires 64 steps to achieve a result of comparable accuracy. SLIM required only 16 phase-encoding steps to obtain accurate regional single slice spectra in a human limb with three compartments. Spectra of similar quality, obtained by Fourier transform chemical-shift imaging, required 256 to 1024 steps.
Selective text utilization and text traversal (1993)

of full-text documents are currently stored in machine-readable form and processed automatically in various ways. These collections may include different types of documents, such as messages, research articles, and books, and the subject matter may vary widely.
Cholesterol-sphingomyelin interactions in cells--effects on lipid metabolism. (1997)

Both cholesterol and sphingomyelin are important constituents of cellular plasma membranes. The molecules are chemically and functionally very different, yet they appear to be attracted to each other in the membrane compartment. It is the aim of this review to discuss how alterations in their membrane interactions may affect lipid homeostasis in cells, and to suggest a molecular explanation for their mutual affinity in membranes. Recent reviews dealing with the subcellular distribution and transport of cholesterol (Liscum and Dahl, 1992; Liscum and Faust, 1994; Liscum and Underwood, 1995), with cellular lipid traffic (van Meer, 1989;Pagano, 1990; Voelker, 1991; Allan and Kallen, 1993), with transport and metabolism of sphingomyelin (Koval and Pagano, 1991), and with the role of sphingolipids in cell signaling (Kolesnick, 1991, 1994; Hannun and Bell, 1993; Hannun, 1994), may also be of interest to the reader.
Influenza and atherosclerosis: vaccination for cardiovascular disease prevention (2005)

In both animal and human studies, strong prothrombotic and pro-inflammatory effects have been observed after influenza infection. Influenza is an important trigger for acute coronary syndromes, and it has been shown that in the US it may cause up to 90,000 deaths per year simply by triggering fatal myocardial infarctions. Multiple case-control and cohort studies have shown that the influenza vaccine has a marked protective effect against cardiovascular events, decreasing the incidence of these events by 20 - 70% in the settings of primary and secondary prevention. Although influenza vaccination is an extremely cost-effective method of cardiovascular protection and is recommended for all patients with cardiac diseases, it is largely underused in these patients. Therefore, increased efforts should be directed towards educating physicians and patients about the benefits of influenza vaccination in patients with coronary heart disease.
In vivo Antiretroviral Efficacy of Oral bis(POM)-PMEA, the bis(Pivaloyloxymethyl)prodrug of 9-(2-Phosphonylmethoxyethyl) adenine (PMEA) (1995)

Abstract The bis-pivaloyloxymethyl(POM)- and diphenyl-ester prodrugs of the broad spectrum antiviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) have been evaluated in vivo for antiviral efficacy upon oral administration in severe combined immune deficiency (SCID) mice infected with Moloney murine sarcoma virus (MSV). Oral bis (POM)-PMEA proved highly efficient in delaying MSV-induced tumor formation and associated death, its effect being equal to that of subcutaneous PMEA at an equimolar dose. Compared to bis(POM)-PMEA, oral diphenyl-PMEA had lower antiviral efficacy, whereas PMEA as such was poorly effective when administered orally. Our studies indicate that bis(POM)-PMEA must have a favorable oral bioavailability and justify its clinical investigation as an oral prodrug of PMEA in the treatment of HIV infections.
Fluorescence probing of inverted micelles. The state of solubilized water clusters in alkane/diisooctyl sulfosuccinate (aerosol OT) solution (1976)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTFluorescence probing of inverted micelles. The state of solubilized water clusters in alkane/diisooctyl sulfosuccinate (aerosol OT) solutionM. Wong, J. K. Thomas, and M. GraetzelCite this: J. Am. Chem. Soc. 1976, 98, 9, 2391–2397Publication Date (Print):April 1, 1976Publication History Published online1 May 2002Published inissue 1 April 1976https://doi.org/10.1021/ja00425a004RIGHTS & PERMISSIONSArticle Views563Altmetric-Citations298LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (754 KB) Get e-Alerts Get e-Alerts
Transgenic models of HIV-1. (1995)

Transgenic technology has been very successful at providing insights into possible processes involved in HIV-induced pathogenesis. The availability of these small animal models for the study of HIV-related syndromes including KS, epidermal proliferative lesions, HIV-associated nephropathy, AIDS-related growth failure and cachexia may well facilitate the development of novel therapies for these complications. Other phenotypes created in mice, such as cataracts and hepatic cancer [59], may not have human analogies but may still provide insight into pathogenesis. Thus, transgenic models have already provided resources to study many manifestations of AIDS and others are likely to be developed. The optimal strategy for designing future transgenic animals, however, is less clear. No transgenic mouse model has been generated to date that will provide an avenue for vaccine development. This advance awaits the further discovery of the host factors that facilitate the virus replicative cycle in humans and a better understanding of these pathways in the mouse. For the development of molecular-based therapy, however, the currently available models may well be adequate to test molecular inhibitors of transcription [7,60,61] and post-transcriptional processing of viral mRNA [62]. Whether single or multigenic constructs under the control of the LTR are better or worse for this purpose is a debatable issue. Transgenic technology may yet make an additional contribution to the development of molecular therapy for AIDS. The best method of demonstrating that a gene therapeutic strategy is safe to administer to patients has not been determined. By introducing potentially therapeutic constructs into mice as transgenes, their safety can be assessed in many different cell types in vivo, analogous to toxicological testing in rodents for systemically administered drugs. Thus, transgenic technology has already provided insights into the pathogenesis of HIV-1. While it has not yet proven its utility for vaccine development, transgenic technology holds the promise of being an active participant in the development of both safe and effective gene therapy approaches for the treatment of AIDS.
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease (2006)

Hyperphosphorylated tau protein (P-tau) in CSF is a core biomarker candidate of Alzheimer's disease. Hyperphosphorylation of tau is thought to lead to neurofibrillary changes, a neuropathological hallmark of this type of dementia. Currently, the question is unresolved whether CSF levels of P-tau reflect neurofibrillary changes within the brain of a patient with the illness. Twenty-six patients were included with intra-vitam CSF as well as post-mortem neuropathological data. In the CSF, P-tau phosphorylated at threonine 231 (P-tau231P) was analysed. Post-mortem, scores of neurofibrillary tangles (NFT) and neuritic plaques (NP) were assessed in frontal, temporal, parietal and hippocampal cortical areas. In the same cortical regions, load of hyperphosphorylated tau protein (HP-tau load) was determined. Concentrations of P-tau231P were measured in frontal cortex homogenates. We found significant correlations between CSF P-tau231P concentrations and scores of NFTs and HP-tau load in all neocortical regions studied. The score of NPs was correlated with CSF P-tau231P only within the frontal cortex. There was a correlation between P-tau231P in CSF and brain homogenates. These findings indicate that CSF P-tau231P may serve as an in vivo surrogate biomarker of neurofibrillary pathology in Alzheimer's disease.
Highly Efficient Gene Delivery for Bladder Cancers by Intravesically Administered Replication-Competent Retroviral Vectors (2007)

Intravesically administered RCR vectors can efficiently deliver genes to orthotopic bladder tumor without viral spread in distant organs. RCR-CD/5-FC suicide gene therapy promises to be a novel and potentially therapeutic modality for bladder cancer.
Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma (2014)

Itraconazole has anti-BCC activity in humans. These results provide the basis for larger trials of longer duration to measure the clinical efficacy of itraconazole, especially relative to other HH pathway inhibitors.
Localization of Romano-Ward long QT syndrome gene, LQT1, to the interval between tyrosine hydroxylase (TH) and D11S1349. (1995)

The Romano-Ward long-QT syndrome (RWLQTS) is an autosomal dominant disorder that is characterized by heritable prolongation of the QT interval, syncope, and sudden death. Identification of the gene responsible for this syndrome may aid the diagnosis, management, and treatment of patients with this disease. Furthermore, it may lead to improved understanding of and therapy for other sympathetic-dependent ventricular arrhythmias. 20 refs., 1 fig., 1 tab.